Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003471615 | SCV004192170 | uncertain significance | Familial adenomatous polyposis 3 | 2023-05-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004364789 | SCV005019818 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-11-22 | criteria provided, single submitter | clinical testing | The p.A123T variant (also known as c.367G>A), located in coding exon 2 of the NTHL1 gene, results from a G to A substitution at nucleotide position 367. The alanine at codon 123 is replaced by threonine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |